Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT04137588 · UNKNOWN
Trial details
- NCT number
- NCT04137588
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-03
- Primary completion
- 2022-03-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.